Skip to content

The application of Fetal HQ technology to assess the impact of pregnancy complicated with autoimmune diseases on fetal cardiac function.

The application of Fetal HQ technology to assess the impact of pregnancy complicated with autoimmune diseases on fetal cardiac function.

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104722
Enrollment
Unknown
Registered
2025-06-23
Start date
2025-06-23
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune diseases in pregnant women

Interventions

normal group:no
Autoimmune disease group:no

Sponsors

Shengjing Hospital Affiliated to China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. The inclusion criteria were that the various growth indicators of the fetus measured by ultrasound were consistent with the gestational age, and there were no known identifiable genetic or chromosomal abnormalities. 2. During pregnancy, the pregnant woman has no pregnancy complications such as diabetes, hypertension or heart disease. 3. The antibody test of pregnant women showed that the autoantibodies in the experimental group were positive while those in the control group were negative. 4. All the enrolled cases had clear images, the targets were located in the center of the images, the backgrounds were pure and unobstructed, and the four chambers of the fetal heart could be clearly displayed.

Exclusion criteria

Exclusion criteria: 1. Multiple pregnancies or fetal chromosomal abnormalities; 2. Maternal smoking history, drinking history, hypertension, diabetes, heart and liver diseases and other chronic diseases; 3. Abnormal fetal heart structure

Design outcomes

Primary

MeasureTime frame
GSI;LVEF;LVSWS;

Secondary

MeasureTime frame
Umbilical artery velocity ratio;

Countries

China

Contacts

Public ContactYu Wang

Shengjing Hospital Affiliated to China Medical University

sea_186@126.com+86 189 4025 7832

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026